OMERS Administration Corp
KRYS icon

OMERS Administration Corp’s Krystal Biotech KRYS Stock Holding History

OMERS Administration Corp’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.29M Hold
3,880
– – 0.01% 659
2026
Q2 		$1.44M Sell
3,880
-220
-5% -$65.7K 0.01% 620
2026
Q1 		$1.06M Buy
+4,100
New +$1.09M 0.01% 639
2025
Q4 		– Sell
-4,000
Closed -$706K – 1210
2025
Q3 		$706K Buy
+4,000
New +$599K 0.01% 651
2024
Q2 		– Sell
-8,200
Closed -$1.46M – 1140
2024
Q1 		$1.46M Buy
+8,200
New +$1.14M 0.02% 138

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

OMERS Administration Corp's KRYS Position: Q3 2026 in Review

OMERS Administration Corp held its Krystal Biotech (KRYS) position steady in Q3 2026 at 3,880 shares worth $1.29M. The position accounts for 0.01% of the portfolio, ranked #659.

OMERS Administration Corp first reported a position in KRYS in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.46M in Q1 2024. 353 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • OMERS Administration Corp held 3,880 shares of Krystal Biotech worth $1.29M as of Q3 2026.
  • OMERS Administration Corp left its Krystal Biotech share count unchanged in Q3 2026.
  • Krystal Biotech made up 0.01% of OMERS Administration Corp's portfolio in Q3 2026, its #659 holding.
  • OMERS Administration Corp first reported a position in Krystal Biotech in Q1 2024 and has held it in 5 quarters since.
  • OMERS Administration Corp's Krystal Biotech position peaked at $1.46M in Q1 2024.
  • 353 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on OMERS Administration Corp's 13F filing for Q3 2026, filed 13 Nov 2026.